The TTTAn aromatase (CYP19A1) polymorphism is associated with compulsive craving of male patients during alcohol withdrawal

被引:10
|
作者
Lenz, Bernd [1 ]
Heberlein, Annemarie [1 ,2 ]
Bayerlein, Kristina [1 ]
Frieling, Helge [1 ,2 ]
Kornhuber, Johannes [1 ]
Bleich, Stefan [1 ,2 ]
Hillemacher, Thomas [1 ,2 ]
机构
[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany
[2] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Ctr Addict Res CARe, D-3000 Hannover, Germany
关键词
Alcohol; Dependence; Addiction; Craving; Aromatase; Sex hormones; Leptin; CYP19A1; TESTOSTERONE; ESTRADIOL; LEPTIN;
D O I
10.1016/j.psyneuen.2011.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alcoholism is associated with alterations of the hypothalamus pituitary gonadal hormone axis. We recently reported a leptin-mediated relation between the CAGn polymorphism of the androgen receptor and craving during alcohol withdrawal. This study investigated whether the TTTAn polymorphism of the aromatase (CYP19A1) is equally linked to craving. An association between TTTAn and compulsive craving (p = 0.029) was revealed in our sample of 118 male alcohol addicts at day of hospital admission. Genotype-dependent subgroups showed differences in that the patients with short alleles suffered from lower compulsive craving during withdrawal than those with the longer alleles (p = 0.027). The additional inclusion of leptin revealed no further significant association in the present study. Our finding is a further step on the way to elucidate the genesis of craving for alcohol with its extensive underlying interactions of different genetic and non-genetic factors. Future investigations should enrol women and consider sex hormone levels for further clarification of the observed TTTAn-craving relationship. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1261 / 1264
页数:4
相关论文
共 50 条
  • [41] Between-female variation in house sparrow yolk testosterone concentration is negatively associated with CYP19A1 (aromatase) mRNA expression in ovarian follicles
    Egbert, Jeremy R.
    Jackson, Melissa F.
    Rodgers, Buel D.
    Schwabl, Hubert
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2013, 183 : 53 - 62
  • [42] Masculine Epigenetic Sex Marks of the CYP19A1/Aromatase Promoter in Genetically Male Chicken Embryonic Gonads Are Resistant to Estrogen-Induced Phenotypic Sex Conversion
    Ellis, Haley L.
    Shioda, Keiko
    Rosenthal, Noel F.
    Coser, Kathryn R.
    Shioda, Toshi
    BIOLOGY OF REPRODUCTION, 2012, 87 (01)
  • [43] The relationship between the CYP2C19*17 genetic polymorphism and the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome
    Skryabin, V. Yu
    Zastrozhin, M. S.
    Grishina, E. A.
    Ryzhikova, K. A.
    Shipitsyn, V. V.
    Barna, I., V
    Galaktionova, T. E.
    Sorokin, A. S.
    Bryun, E. A.
    Sychev, D. A.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 119 - 126
  • [44] Characterization and expression profile of the ovarian cytochrome p-450 aromatase (cyp19A1) gene during thermolabile sex determination in pejerrey, Odontesthes bonariensis
    Karube, Makiko
    Fernandino, Juan Ignacio
    Strobl-Mazzulla, Pablo
    Strussmann, Carlos Augusto
    Yoshizaki, Goro
    Somoza, Gustavo Manuel
    Patino, Reynaldo
    JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL AND INTEGRATIVE PHYSIOLOGY, 2007, 307A (11) : 625 - 636
  • [45] CYP19A1 rs10046 Pharmacogenetics in Postmenopausal Breast Cancer Patients Treated with Aromatase Inhibitors: One-year Follow-up
    Baatjes, Karin
    Peeters, Armand
    McCaul, Micheal
    Conradie, Maria M.
    Apffelstaedt, Justus
    Conradie, Magda
    Kotze, Maritha J.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (46) : 6007 - 6012
  • [46] Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
    Park, In Hae
    Lee, Yeon-Su
    Lee, Keun Seok
    Kim, Sook-young
    Hong, Seung-Hyun
    Jeong, Jaeheon
    Lee, Hyewon
    Ro, Jungsil
    Nam, Byung-Ho
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1263 - 1271
  • [47] Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
    In Hae Park
    Yeon-Su Lee
    Keun Seok Lee
    Sook-young Kim
    Seung-Hyun Hong
    Jaeheon Jeong
    Hyewon Lee
    Jungsil Ro
    Byung-Ho Nam
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1263 - 1271
  • [48] Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer
    Shao, Xiying
    Luo, Lei
    Guo, Yong
    Xu, Xiaohong
    Deng, Dehou
    Feng, Jianguo
    Ding, Yuheng
    Mou, Hanzhou
    Huang, Ping
    Shi, Lei
    Huang, Yuan
    Ye, Weiwu
    Lou, Caijin
    Chen, Zhanhong
    Zheng, Yabing
    Wang, Xiaojia
    ONCOLOGY LETTERS, 2017, 14 (05) : 6156 - 6162
  • [49] Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies
    Bouchoucha, Nadia
    Samara-Boustani, Dinane
    Pandey, Amit V.
    Bony-Trifunovic, Helene
    Hofer, Gaby
    Aigrain, Yves
    Polak, Michel
    Flueck, Christa E.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 390 (1-2) : 8 - 17
  • [50] CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
    Melchardt, Thomas
    Hufnagl, Clemens
    Magnes, Teresa
    Weiss, Lukas
    Hutarew, Georg
    Neureiter, Daniel
    Schlattau, Alexander
    Moser, Gerhard
    Gaggl, Alexander
    Traenkenschuh, Wolfgang
    Greil, Richard
    Egle, Alexander
    BMC CANCER, 2015, 15